Skip to main content
Caplight Logo









Dillico

Dillico

Private
MeylanHealthcare & Life Scienceshttps://dillico.com/

Last Round

Seed

Jul 9, 2025

Total Funding Raised

$8.77M

Company Overview

Dillico is a biotechnology company that develops integrated, continuous, and digitized manufacturing solutions for mRNA-LNP therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

mRNA manufacturingcontinuous manufacturingmRNA productionbiotech manufacturingLNP therapeuticsbioprocess automationdigital twinflow chemistrypharma 4.0biotech equipmentin-silico modelingprocess developmentsmart manufacturingmodular bioprocessinglab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dillico Comparables

Compare Dillico with similar companies based on industry and business-model similarity.

Dillico comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inside Therapeutics
86%
DIANT Pharma Inc.
84%
Helix Biotech
81%

Dillico Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 9, 2025

Key People

Founding team and executive leadership

Emmanuel Gaud

COO & Co-Founder

Founding Team

Flora Binder

Co-founder and Development Director Chief Development Officer

Founding Team

Christophe BONNEVILLE

Co-Founder & CEO

Founding Team

Dillico Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 36% MoM, from 111 to 151.

  • Jan 20, 2026

    Grew 33% QoQ from 9 to 12 employees.

Dillico Filings

Explore SEC and related filing metadata, where available.

Dillico filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dillico's valuation, stock price, and market status.

Is Dillico a public or private company?

Dillico is a private company.

What is the current stock price of Dillico?

Dillico is a private company with no public stock price. No recent secondary market data is available.

How much is Dillico worth (valuation)?

Valuation information for Dillico is not publicly available.

Can I buy Dillico stock?

Dillico shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dillico's last funding round?

Dillico's most recent funding round was Seed on July 9, 2025.

Who are the main investors in Dillico?

Key investors in Dillico include Fonds Régional Avenir Industrie Auvergne-Rhône-Alpes, Angelor, Bpifrance, UI Investissement.

Will Dillico IPO soon?

No public IPO plans have been announced for Dillico.

How can I track Dillico secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dillico's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMeylan
Employee Range13
Year Founded2022
Last FundingJul 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?